Blood pressure breakthrough holds real hope for treatment of pre-eclampsia

Oct 06, 2010

Scientists have discovered a mechanism which raises blood pressure in pre-eclampsia, a potentially deadly condition which occurs during pregnancy.

After 20 years of research, scientists from the University of Cambridge have now cracked the first step in the main process that controls . Their findings, published today in the journal Nature, are likely to have significant implications for the treatment of pre-eclampsia as well as (also known as hypertension).

Blood pressure is controlled by hormones called angiotensins, which cause the blood vessels to constrict. These hormones are released by the protein angiotensinogen. Until now, it was not understood how this occurred.

Dr Aiwu Zhou, a British Heart Foundation (BHF) Fellow at the University of Cambridge, who made the breakthrough, said: "Although we primarily focused on pre-eclampsia, the research also opens new leads for future research into the causes of hypertension in general."

To make the discovery, the researchers solved the structure of angiotensinogen with the help of an extremely intense X-ray beam produced by Diamond Light Source, the UK synchrotron. Their results revealed that the protein is oxidised and changes shape
to permit ready access to angiotensinogen by an enzyme, renin. Renin cuts off the tail of the protein to release the hormone angiotensin, which then raises blood pressure.

Taking their lab results into the clinic at the University of Nottingham, the research team showed that the amount of oxidised, and hence more active, angiotensinogen was increased in women with pre-eclampsia.

Professor Robin Carrell at the University of Cambridge, who led the 20-year research project, explained: "During pregnancy oxidative changes can occur in the placenta. These changes, the very ones we have found stimulates the release of the hormone angiotensin and lead to increased blood pressure, can arise as the circulation in the placenta readjusts the oxygen requirements of the growing foetus with the delivery of oxygen to the from the mother."

Drugs currently used to treat high blood pressure – such as ACE inhibitors - focus on the later stages of the mechanism that controls blood pressure. Today's findings, which give insight into the previously mysterious early stages of the regulation process, provide scientists with new opportunities to research novel treatments for hypertension.

Professor Peter Weissberg, Medical Director of the BHF, which largely funded the study, said: "Every year in the UK pre-eclampsia is responsible for the deaths of around six women and several hundred babies. This research is of the highest quality and offers real hope for developing strategies to prevent or treat this dangerous condition by targeting the process that these scientists have identified. And of course, although the researchers only looked at pre-eclampsia in this study, similar strategies may be useful for those people with high blood pressure that is not effectively controlled by current medicines."

High blood pressure frequently affects pregnancy. However, in 2-7 per cent of pregnancies this develops into pre-eclampsia, which threatens the health and survival of both the mother and child. In Britain, it affects about one in 20 women during pregnancy, and every year 50,000 women and 500,000 infants die globally as a result of pre-eclampsia. There is no treatment for pre-eclampsia and often the mother is either induced early or undergoes a Caesarean.

Explore further: Secret of tetanus toxicity offers new way to treat motor neuron disease

More information: The paper 'A redox switch in angiotensinogen modulates angiotensin release' will be published in the 06 October 2010 edition of Nature.

Related Stories

Pre-eclampsia linked to thyroid problems

Nov 18, 2009

Women who develop pre-eclampsia during pregnancy are more likely than other women to have reduced thyroid function (hypothyroidism), finds a study published in BMJ today. It may also put women at a greater risk of thyroi ...

Pregnancy disorder signals need to screen for heart disease

Nov 04, 2008

High blood pressure experienced during pregnancy could be a woman's earliest warning that she is at risk of developing heart disease – the number one killer of Canadian women – says Queen's University professor of Obstetrics ...

Previous abortions and exercise: Do they affect pregnancy?

Nov 11, 2008

Women who have had two or more induced abortions have a reduced risk of pre-eclampsia by 60 %. It is not currently understood to what degree physical activity during pregnancy protects against pre-eclampsia, compared to previous ...

Pre-eclampsia may be autoimmune disease

Jul 28, 2008

Biochemists at The University of Texas Medical School at Houston say they are the first to provide pre-clinical evidence that pregnancy-induced high blood pressure or pre-eclampsia may be an autoimmune disease. Their research ...

Recommended for you

Stroke damage mechanism identified

Nov 27, 2014

Researchers have discovered a mechanism linked to the brain damage often suffered by stroke victims—and are now searching for drugs to block it.

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

tkjtkj
not rated yet Oct 06, 2010
There is no treatment for pre-eclampsia


This seems to be a very important piece of work.
(But delivery of the baby is a treatment for pre-eclampsia.

tkjtkj@gmail.com , md
AethyrDragon
not rated yet Oct 07, 2010
Delivery of baby only works if the feotus is viable - otherwise you're looking a termination of the pregnancy and the death of the feotus. In subsequent pregnancies pre-eclampsia / eclampsia starts earlier than the first.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.